Isolated fecal microorganisms capable of 7-alpha-dehydroxylating bile acids.

Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A (2010) 3.51

Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity. Appl Environ Microbiol (1987) 2.14

Intestinal bacteria. The role they play in normal physiology, pathologic physiology, and infection. Calif Med (1969) 1.64

Absorption of bile acids from the large bowel in man. J Clin Invest (1968) 1.55

Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids. Appl Environ Microbiol (1981) 1.36

Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut (1992) 1.14

Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes. Appl Environ Microbiol (1997) 1.13

Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.09

Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut (2001) 1.06

Multiple copies of a bile acid-inducible gene in Eubacterium sp. strain VPI 12708. J Bacteriol (1990) 1.02

Cooperative formation of omega-muricholic acid by intestinal microorganisms. Appl Environ Microbiol (1983) 1.01

Bacterial formation of omega-muricholic acid in rats. Appl Environ Microbiol (1979) 0.96

Cholestasis induced by sodium taurolithocholate in isolated hamster liver. J Clin Invest (1971) 0.93

7 alpha-Dehydroxylation of bile acids by resting cells of a Eubacterium lentum-like intestinal anaerobe, strain c-25. Appl Environ Microbiol (1984) 0.81

7 alpha-Dehydroxylation of bile acids by resting cells of an unidentified, gram-positive, nonsporeforming anaerobic bacterium. Appl Environ Microbiol (1983) 0.78

Lightweight stainless steel systems for rearing germfree animals. Ann N Y Acad Sci (1959) 2.51

On the transformation and enterohepatic circulation of cholic acid in the rat: bile acids and steroids 68. J Biol Chem (1958) 2.00

Hydrolysis of conjugated bile acids by Clostridia and enterococci; bile acids and steroids 25. Acta Pathol Microbiol Scand (1955) 2.00

On the turnover and excretory products of cholic and chenodeoxycholic acid in man. J Biol Chem (1963) 1.87

In vitro formation of deoxycholic and lithocholic acid by human intestinal microorganisms. Proc Soc Exp Biol Med (1962) 1.79

The effect of oral neomycin on the conversion of cholic acid to deoxycholic in man. Arch Biochem Biophys (1963) 1.55

Turnover and nature of fecal bile acids in germfree and infected rats fed cholic acid-24-14C; bile acids and steroids 41. Proc Soc Exp Biol Med (1957) 1.47

The microbiological degradation of steroids: 4. Fission of the steroid molecule. Biochem J (1948) 1.45

METABOLITES OF LITHOCHOLIC ACID-24-C-14 IN HUMAN BILE AND FECES. J Lab Clin Med (1964) 1.38

Synthesis of some 3beta-hydroxylated bile acids and the isolation of 3beta, 12alpha-dihydroxy-5beta-cholanic acid from feces. J Biol Chem (1962) 1.33

Alteration of bile salts by bacteria. Proc Soc Exp Biol Med (1962) 1.27

[Studies on the quantitative evaluation of thin-layer chromatography. 2. Separation and determination of bile acids]. Arzneimittelforschung (1960) 1.26

Microbiological degradation of cholic acid. Nature (1957) 1.17

TRANSFORMATION OF CHOLIC ACID IN VITRO BY CORYNEBACTERIUM SIMPLEX. BILE ACIDS AND STEROIDS. 132. J Biol Chem (1964) 1.13

Reversible enzymatic oxidation of bile acids. Arch Biochem Biophys (1955) 1.09

Isolation of some bile acids and sterols from the feces of healthy men. Arch Biochem Biophys (1959) 1.06

Influence of E. coli infection on turnover and metabolism of cholic acid in germ-free rats. Arch Biochem Biophys (1960) 0.91

Bacterial oxidation of cholic acid. Arch Biochem Biophys (1954) 0.81

GLOBULAR BODIES OF LACTOBACILLI. Pathol Microbiol (Basel) (1965) 0.81

[Quantitative autoradiography of labelled compounds in paper chromatograms]. Clin Chim Acta (1962) 0.80

On the Interpretation of Multi-Hit Survival Curves. Proc Natl Acad Sci U S A (1949) 5.96

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89

A model of host-microbial interactions in an open mammalian ecosystem. Science (1996) 5.85

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98

A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A (1999) 3.63

Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ (1990) 3.25

Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol (2003) 3.10

Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev (1998) 3.09

Antigen from colon of germfree rats and antibodies in human ulcerative colitis. Ann N Y Acad Sci (1965) 2.72

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71

[Clostridium difficile-associated diarrhea treated with homologous feces]. Tidsskr Nor Laegeforen (1998) 2.55

Bile acid transformations by microbial strains belonging to genera found in intestinal contents. Acta Pathol Microbiol Scand (1967) 2.33

Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci U S A (1994) 2.16

Reconstitution of the gastrointestinal microflora of lactobacillus-free mice. Appl Environ Microbiol (1988) 2.12

Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases. Clin Exp Immunol (1966) 2.11

Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol (1995) 2.08

Immunological studies in ulcerative colitis. IV. Origin of autoantibodies. J Exp Med (1968) 2.02

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02

Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) (1991) 1.89

Short-chain fatty acids in germfree mice and rats. J Nutr (1986) 1.84

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80

Proliferation of human lymphocytes in culture. Nature (1966) 1.76

Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut (2008) 1.75

A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) (2007) 1.75

A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68

FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer (2000) 1.68

Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66

A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61

Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol (1999) 1.59

Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology (1992) 1.56

The mutational spectrum in Waardenburg syndrome. Hum Mol Genet (1995) 1.55

Germ-free and colonized mice generate the same products from enteric prodefensins. J Biol Chem (2000) 1.52

Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol (2001) 1.51

Parameters in 7-alpha-dehydroxylation of bile acids by anaerobic lactobacilli. Acta Pathol Microbiol Scand (1968) 1.50

A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol (2000) 1.49

Microbial bile acid transformation. Am J Clin Nutr (1974) 1.47

Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (2002) 1.45

Assessment of microbial fermentation products in fecal samples. Neurogastroenterol Motil (2010) 1.44

Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules. Aliment Pharmacol Ther (2012) 1.43

A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43

Predicting normal tissue injury in radiation therapy. Int J Radiat Oncol Biol Phys (1991) 1.43

Using intact nerve to bridge peripheral nerve defects: an alternative to the use of nerve grafts. J Hand Surg Am (2001) 1.42

Immunological studies in ulcerative colitis. II. "Colon" antigen and human blood group A- and H-like antigens in germfree rats. J Exp Med (1965) 1.41

Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? Clin Nutr (2005) 1.39

Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.39

Microwave life-detection systems for searching human subjects under earthquake rubble or behind barrier. IEEE Trans Biomed Eng (2000) 1.39

Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38

Relationship between Toxoplasma gondii antibodies and blood group. Eur J Clin Microbiol Infect Dis (1989) 1.38

Quinolones and the environment. Lancet (1989) 1.38

Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy (2000) 1.35

Myositis ossificans with atypical clinical, radiographic, or pathologic findings: a review of 23 cases. Skeletal Radiol (1992) 1.34

The physiological importance of the colonic microflora. Scand J Gastroenterol Suppl (1982) 1.33

Determination of bile acid conversion potencies of intestinal bacteria by screening in vitro and subsequent establishment in germfree rats. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.32

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer (1995) 1.31

Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30

Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig Dis Sci (1994) 1.29

Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest (1986) 1.29

Distended left renal vein: CT/sonographic normal variant. AJR Am J Roentgenol (1980) 1.28

Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer (1999) 1.27

Excretion of 3beta-hydroxy-5-cholenoic and 3a-hydroxy-5a-cholanoic acids in urine of infants with biliary atresia. FEBS Lett (1971) 1.26

Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol (2005) 1.26

Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses. Ann Pharmacother (1992) 1.25

Osteonecrosis of the distal pole of the carpal scaphoid following fracture--a rare complication. Skeletal Radiol (1983) 1.24

Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol (1997) 1.24

Immunological studies in ulcerative colitis. VII. Anti-colon antibodies of different immunoglobulin classes. Clin Exp Immunol (1970) 1.23

Selection against chromosome aberrations in human lymphocytes. Nature (1967) 1.23

Phagocytosis, peritoneal influx, and enzyme activities in peritoneal macrophages from germfree, conventional, and ex-germfree mice. Infect Immun (1984) 1.23

Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications? Clin Oncol (R Coll Radiol) (2004) 1.23

Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology (1994) 1.21

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. Ann Oncol (2008) 1.18

Bile acids and pancreatic enzymes during absorption in the newborn. Acta Paediatr Scand (1972) 1.17

Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer (2005) 1.15

The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer (1998) 1.15

Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. J Clin Invest (1978) 1.14

The induction of micronuclei in human lymphocytes by low doses of radiation. Int J Radiat Biol Relat Stud Phys Chem Med (1987) 1.14

Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol (2002) 1.14

Intracapsular and paraarticular chondromas. Clin Orthop Relat Res (1994) 1.14

Origin of lignans in mammals and identification of a precursor from plants. Nature (1982) 1.13

Influence of oral intake of seven different antibiotics on faecal short-chain fatty acid excretion in healthy subjects. Scand J Gastroenterol (1986) 1.12

Are we discussing SUDEP?--A retrospective case note analysis. Seizure (2012) 1.11

Radial head-capitellum view in elbow trauma: clinical application and radiographic-anatomic correlation. AJR Am J Roentgenol (1984) 1.11

Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization. Clin Diagn Lab Immunol (1999) 1.10

Origin of intestinal beta-glucuronidase in germfree, monocontaminated and conventional rats. Acta Pathol Microbiol Scand B (1977) 1.10

CD1high B cells: a population of mixed origin. Eur J Immunol (1999) 1.10

Radiation stimulated incorporation of thymidine into the DNA of human lymphocytes. Nature (1968) 1.09

Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.09

Gross hematuria: a complication of intrapelvic cement intrusion in total hip replacement. AJR Am J Roentgenol (1978) 1.09

Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. J Clin Oncol (2003) 1.09

Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine. Immunology (1996) 1.08

The establishment of some microflora associated biochemical characteristics in feces from children during the first years of life. Acta Paediatr Scand (1985) 1.08

A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer (2005) 1.07

The relevance of gene transfer to the safety of food and feed derived from genetically modified (GM) plants. Food Chem Toxicol (2004) 1.07

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. Prostate Cancer Prostatic Dis (2008) 1.07

The acute neuropathic arthropathy--a rapid, severely disorganizing form of arthritis. Radiology (1968) 1.07

Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J Med Genet (2007) 1.07

Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol (1998) 1.05